Company: BKYI
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001437749-25-035227
Chunk: 2

Company: BIO KEY INTERNATIONAL INC
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
   4,843,529 
         
 Commitments and Contingencies           
         
 STOCKHOLDERS’ EQUITY         
         
 Common stock — authorized, 170,000,000 shares; issued and outstanding; 7,313,423 and 3,715,483 of $.0001 par value at September 30, 2025 and December 31, 2024, respectively   731   372 
 Additional paid-in capital   138,180,051   133,030,271 
 Accumulated other comprehensive income   40,988   49,290 
 Accumulated deficit   (132,176,692)  (129,307,902)
 TOTAL STOCKHOLDERS’ EQUITY   6,045,078   3,772,031 
 TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $10,113,313  $8,615,560 

See accompanying notes to the condensed consolidated financial statements.  

     3

      Table of Contents

BIO-KEY INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(Unaudited)

       Three Months Ended 

       Nine Months Ended 

       September 30, 

       September 30, 

       2025 

       2024 

       2025 

       2024 

       Revenues 

       Services 
       
      $
      268,113

      $
      267,371

      $
      862,707

      $
      764,062

       License fees 

      917,951

      1,441,011

      2,822,796

      4,165,669

       Hardware 

      363,642

      436,422

      1,168,269

      537,562

       Total revenues 

      1,549,706

      2,144,804

      4,853,772

      5,467,293

       Costs and other expenses 

       Cost of services 

      80,702

      110,723

      297,147

      322,957

       Cost of license fees 

      74,077

      146,732

      233,450

      443,384